Cooper Companies (COO) Total Non-Current Liabilities (2010 - 2026)
Cooper Companies (COO) posted Total Non-Current Liabilities of $4.0 billion for Q2 2026, up 5.12% on a QoQ basis from $3.8 billion in Q1 2026, and up 3.26% year-over-year from $3.9 billion in Q2 2025.
Analysis
Cooper Companies (COO) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Cooper Companies has reported Total Non-Current Liabilities for 12 years, with the latest figure at $4.0 billion in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 3.26% year-over-year to $4.0 billion in Q2 2026; TTM through Apr 2026 was $4.0 billion, a 3.26% increase from a year earlier, with the FY2025 full-year figure at $3.9 billion, down 1.2% from the prior year.
- Total Non-Current Liabilities was $4.0 billion for Q2 2026 at Cooper Companies, up from $3.8 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $4.6 billion in Q2 2022, with the low at $3.8 billion in Q3 2025.
- Average Total Non-Current Liabilities over 5 years is $4.0 billion, with a median of $4.0 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities surged 66.18% in 2022, then declined 12.23% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $4.1 billion in 2022, then dropped by 5.47% to $3.9 billion in 2023, then grew by 1.33% to $3.9 billion in 2024, then dropped by 1.2% to $3.9 billion in 2025, then gained by 2.68% to $4.0 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $4.0 billion (Q2 2026), $3.8 billion (Q1 2026), and $3.9 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn | 3.98 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 3.98 Bn |
| Jan 31, 2026 | 3.78 Bn |
| Oct 31, 2025 | 3.87 Bn |
| Jul 31, 2025 | 3.76 Bn |
| Apr 30, 2025 | 3.85 Bn |
| Jan 31, 2025 | 3.83 Bn |
| Oct 31, 2024 | 3.92 Bn |
| Jul 31, 2024 | 3.91 Bn |
| Apr 30, 2024 | 3.97 Bn |
| Jan 31, 2024 | 4.06 Bn |
| Oct 31, 2023 | 3.87 Bn |
| Jul 31, 2023 | 4.08 Bn |
| Apr 30, 2023 | 4.07 Bn |
| Jan 31, 2023 | 4.11 Bn |
| Oct 31, 2022 | 4.09 Bn |
| Jul 31, 2022 | 4.35 Bn |
| Apr 30, 2022 | 4.64 Bn |
| Jan 31, 2022 | 4.60 Bn |
| Oct 31, 2021 | 2.52 Bn |
| Jul 31, 2021 | 2.69 Bn |